Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention

Heart and Vessels

Volumn 21, Issue 3, 2006, Pages 146-151

  Veselka, Josef ^a   Procházková, Šárka ^a   Duchoňová, Radka ^a   Homolová, Ingrid ^a   Tesař, David ^a   Bybee, Kevin A ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b MAYO CLINIC   (United States)

Author keywords

Angioplasty; Statin; Stent; Troponin

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; CLOPIDOGREL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; TICLOPIDINE; TROPONIN I;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROTEIN SECRETION; RISK REDUCTION; STABLE ANGINA PECTORIS; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PILOT PROJECTS; SIMVASTATIN; TROPONIN;

EID: 33646761335     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-005-0885-x     Document Type: Article

References (27)

1. FM Sacks MA Pfeffer LA Moye 1996 The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1001-1009 8801446 1:CAS:528:DyaK28XmsFWls7c%3D 10.1056/NEJM199610033351401
2. Scandinavian Simvastatin Survival Study Group 1994 Randomised trial of cholesterol lowering 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1383-1389
3. J Sheperd S Cobb I Ford 1995 Prevention of coronary heart disease in men with hypercholesterolemia N Engl J Med 333 1301-1307 10.1056/ NEJM199511163332001
4. Heart Protection Study Collaborative Group 2002 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomized, placebo controlled trial Lancet 360 7-22 10.1016/S0140-6736(02)09327-3
5. LM Blanco-Colio A Villa M Ortego 2002 3-Hydroxy-3methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation Atherosclerosis 161 17-26 11882313 1:CAS:528:DC%2BD38XhslWhtrw%3D 10.1016/S0021-9150(01)00613-X
6. RD Danesh YS Kanwar 2004 Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy FASEB J 18 805-815 15117885 1:CAS:528:DC%2BD2cXjvVOntrc%3D 10.1096/fj.03-0839rev
7. L Lacoste JYT Lam 1996 Comparative effect of pravastatin and simvastatin on platelet thrombus formation in hypercholesterolemic coronary patients J Am Coll Cardiol 27 413A10.1016/S0735-1097(96)82590-3
8. U Laufs V Fata J Plutzky K Liao 1998 Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors Circulation 97 1129-1135 9537338 1:CAS:528:DyaK1cXisVWmsrY%3D
9. M Weis C Heeschen AJ Classford JP Cooke 2002 Statins have biphasic effects on angiogenesis Circulation 105 739-745 11839631 1:CAS:528:DC%2BD38XitFais7c%3D 10.1161/hc0602.103393
10. CB Xu E Stenmann L Edvinsson 2002 Reduction of bFGF-induced smooth muscle proliferation and endothelin receptor RNA expression by mevastatin and atorvastatin Biochem Pharmacol 64 497-505 12147302 1:CAS:528:DC%2BD38XlvVWmtrg%3D 10.1016/S0006-2952(02)01189-9
11. MA Albert E Danielson N Riafai PM Ridker 2001 Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study JAMA 286 64-70 11434828 1:CAS:528:DC%2BD3MXltleit74%3D 10.1001/jama.286.1.64
12. C Tiefenbacher J Kapitza V Dietz CH Lee F Niroomand 2003 Reduction of myocardial infarction size by fluvastatin Am J Physiol Heart Circ Physiol 285 H59-H64 12623790 1:CAS:528:DC%2BD3sXlsFGitrw%3D
13. KA Bybee SL Kopecky BA Williams JG Murphy RS Wright 2004 Reduced creatine kinase release with statin use at the time of myocardial infarction Int J Cardiol 96 461-466 15301900 10.1016/j.ijcard.2004.02.016
14. HD Aronow EJ Topol MT Roe 2001 Effect of lipid-lowering therapy on early mortality after acutecoronary syndromes: An observational study Lancet 357 1063-1068 11297956 1:STN:280:DC%2BD3M3jslyrtw%3D%3D 10.1016/ S0140-6736(00)04257-4
15. KA Bybee RS Wright B Williams J Murphy D Holmes S Kopecky 2001 Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction rates in patients with acute myocardial infarction Am J Cardiol 87 771-774 11249901 1:CAS:528:DC%2BD3MXhvVamsLo%3D 10.1016/ S0002-9149(00)01501-0
16. U Stenestrand L Wallentin 2001 Early statin treatment following acute myocardial infarction and 1-year survival JAMA 285 430-436 11242427 1:CAS:528:DC%2BD3MXhtVehu7c%3D 10.1001/jama.285.4.430
17. GG Schwartz AG Olsson MD Ezekowitz 2001 Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL Study JAMA 285 1711-1718 11277825 1:CAS:528:DC%2BD3MXivFGnurc%3D 10.1001/ jama.285.13.1711
18. A Chan DL Bhatt DP Chew 2002 Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation 105 691-696 11839623 1:CAS:528:DC%2BD38XitFais7o%3D 10.1161/hc0602.103586
19. J Herrmann A Lerman D Baumgart 2002 Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction Circulation 106 2180-2183 12390944 1:CAS:528:DC%2BD38Xns1Ogu7c%3D 10.1161/01.CIR.0000037520.89770.5E
20. V Pasceri G Patti A Nusca 2004 Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention Circulation 110 674-678 15277322 1:CAS:528:DC%2BD2cXmtFOhu7g%3D 10.1161/ 01.CIR.0000137828.06205.87
21. J Herrmann C von Birgelen M Haude 2002 Prognostic implication of cardiac troponin T increase following stent implantation Heart 87 549-553 12010937 1:STN:280:DC%2BD383ntFOlsA%3D%3D 10.1136/heart.87.6.549
22. JF Saucedo R Mehran G Dangas 2000 Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting J Am Coll Cardiol 35 1134-1141 10758952 1:CAS:528:DC%2BD3cXivVSru7o%3D 10.1016/S0735-1097(00)00513-1
23. RM Califf AE Abdelmeguid RE Kuntz 1998 Myonecrosis after revascularization procedures J Am Coll Cardiol 31 241-251 9462562 1:STN:280:DyaK1c7it1eqtg%3D%3D 10.1016/S0735-1097(97)00506-8
24. J Veselka M Mates D T,Tesař D.Aschermann M.Urbanová T. Honě 2000 Direct stenting without predilatation: A new approach to coronary intervention Coron Artery Dis 11 503-507 10966137 1:STN:280:DC%2BD3M7ht1Cksg%3D%3D 10.1097/00019501-200009000-00009
25. P Červinka J Št'ástek M Pleskot J Malý 2002 Treatment of coronary bifurcation lesions by stent implantation only in parent vessel and angioplasty in sidebranch: Immediate and long-term outcome J Invas Cardiol 14 735-740
26. CM Chung S Nakanuta K Tanaka 2004 Stenting alone versus debulking and debulking plus stent in branch ostal lesions of native coronary arteries Heart Vessels 19 213-220 15372295 10.1007/s00380-004-0778-4
27. M Tokac A Ozeren M Aktan et al. 2003 The role of inflammation in markers triggering acute coronary events. Heart Vessels 18:150-152